Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses (2017 - 2025)

Historic Interest Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to -$415000.0.

  • Organogenesis Holdings' Interest Expenses fell 18811.04% to -$415000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 19995.25%. This contributed to the annual value of $1.5 million for FY2024, which is 2949.77% down from last year.
  • Per Organogenesis Holdings' latest filing, its Interest Expenses stood at -$415000.0 for Q3 2025, which was down 18811.04% from -$669000.0 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Interest Expenses registered a high of $2.5 million during Q1 2021, and its lowest value of -$961000.0 during Q1 2025.
  • Moreover, its 5-year median value for Interest Expenses was $572000.0 (2022), whereas its average is $575421.1.
  • In the last 5 years, Organogenesis Holdings' Interest Expenses skyrocketed by 177333.33% in 2023 and then plummeted by 28696.5% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Interest Expenses stood at $853000.0 in 2021, then plummeted by 103.52% to -$30000.0 in 2022, then skyrocketed by 1773.33% to $502000.0 in 2023, then tumbled by 112.15% to -$61000.0 in 2024, then tumbled by 580.33% to -$415000.0 in 2025.
  • Its Interest Expenses stands at -$415000.0 for Q3 2025, versus -$669000.0 for Q2 2025 and -$961000.0 for Q1 2025.